<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="brief-report" dtd-version="1.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Oncol.</journal-id>
<journal-title-group>
<journal-title>Frontiers in Oncology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Oncol.</abbrev-journal-title>
</journal-title-group>
<issn pub-type="epub">2234-943X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fonc.2025.1736140</article-id>
<article-version article-version-type="Version of Record" vocab="NISO-RP-8-2008"/>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Perspective</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Colorectal cancer as a complex adaptive system: integrating the hallmarks of cancer with complexity theory</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name><surname>Basbus</surname><given-names>Luis R.</given-names></name>
<xref ref-type="corresp" rid="c001"><sup>*</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/3262364/overview"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Funding acquisition" vocab-term-identifier="https://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x2013; original draft</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Project-administration" vocab-term-identifier="https://credit.niso.org/contributor-roles/project-administration/">Project administration</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &amp; editing</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="resources" vocab-term-identifier="https://credit.niso.org/contributor-roles/resources/">Resources</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="software" vocab-term-identifier="https://credit.niso.org/contributor-roles/software/">Software</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="visualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/visualization/">Visualization</role>
</contrib>
</contrib-group>
<aff id="aff1"><institution>Department of Oncology, Hospital Italiano de Buenos Aires</institution>, <city>Buenos Aires</city>,&#xa0;<country country="ar">Argentina</country></aff>
<author-notes>
<corresp id="c001"><label>*</label>Correspondence: Luis R. Basbus, <email xlink:href="mailto:luis.basbus@hospitalitaliano.org.ar">luis.basbus@hospitalitaliano.org.ar</email></corresp>
</author-notes>
<pub-date publication-format="electronic" date-type="pub" iso-8601-date="2026-02-03">
<day>03</day>
<month>02</month>
<year>2026</year>
</pub-date>
<pub-date publication-format="electronic" date-type="collection">
<year>2025</year>
</pub-date>
<volume>15</volume>
<elocation-id>1736140</elocation-id>
<history>
<date date-type="received">
<day>30</day>
<month>10</month>
<year>2025</year>
</date>
<date date-type="accepted">
<day>19</day>
<month>12</month>
<year>2025</year>
</date>
<date date-type="rev-recd">
<day>09</day>
<month>12</month>
<year>2025</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2026 Basbus.</copyright-statement>
<copyright-year>2026</copyright-year>
<copyright-holder>Basbus</copyright-holder>
<license>
<ali:license_ref start_date="2026-02-03">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
<license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License (CC BY)</ext-link>. The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<abstract>
<p>The paradigm of the <italic>Hallmarks of Cancer</italic>, updated by Douglas Hanahan in 2022, represents one of the most influential syntheses for understanding the functional capabilities that sustain neoplastic transformation. However, its traditional interpretation, often reductionist and fragmentary, does not capture the non-linear, emergent, and adaptive dynamics of tumor behavior. This review proposes a reinterpretation of the hallmarks through the lens of complexity theory, conceptualizing colorectal cancer (CRC) as a self-organizing, open system operating far from equilibrium. Using an integrative conceptual approach, we map the ten classical hallmarks and the new dimensions proposed in 2022 (phenotypic plasticity, non-mutational epigenetic reprogramming, polymorphic microbiomes, and senescence) onto the fundamental properties of complex systems: nonlinearity, emergence, feedback, openness, and historical dependence. We argue that CRC should not be understood as a simple sum of molecular alterations but as a dynamic network of interactions among cells, tissues, and microenvironments where global organization emerges from local rules. This systems-based perspective provides a conceptual foundation for translational models and integrative methodologies in oncology.</p>
</abstract>
<kwd-group>
<kwd>colorectal cancer</kwd>
<kwd>complex systems</kwd>
<kwd>emergence</kwd>
<kwd>hallmarks of cancer</kwd>
<kwd>self-organization</kwd>
<kwd>systems biology</kwd>
</kwd-group>
<funding-group>
<funding-statement>The author(s) declared that financial support was not received for this work and/or its publication.</funding-statement>
</funding-group>
<counts>
<fig-count count="0"/>
<table-count count="1"/>
<equation-count count="0"/>
<ref-count count="30"/>
<page-count count="5"/>
<word-count count="1638"/>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Gastrointestinal Cancers: Colorectal Cancer</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<label>1</label>
<title>Introduction</title>
<p>For decades, cancer has been understood within a reductionist epistemology, as a sequence of genetic alterations that activate oncogenes, inactivate tumor suppressors, and drive uncontrolled proliferation (<xref ref-type="bibr" rid="B1">1</xref>). This model enabled key discoveries in molecular oncology but fails to explain emergent phenomena such as tumor heterogeneity, phenotypic plasticity, therapy resistance, and clonal evolution (<xref ref-type="bibr" rid="B2">2</xref>).</p>
<p>Hanahan&#x2019;s 2022 update of the <italic>Hallmarks of Cancer</italic> expanded the original framework to include new enabling dimensions: non-mutational epigenetic reprogramming, polymorphic microbiomes, cellular senescence, and phenotypic plasticity (<xref ref-type="bibr" rid="B3">3</xref>). This conceptualization reframes cancer as a dynamic, evolving system in which biological capabilities emerge from multilevel interactions among genetic, epigenetic, and environmental components. Hanahan himself emphasizes that the hallmarks are heuristic tools for distilling the vast complexity of cancer phenotypes into a set of underlying organizational principles (<xref ref-type="bibr" rid="B3">3</xref>).</p>
<p>From this view, the tumor is not merely a mass of mutated cells but a <bold>complex adaptive system</bold> composed of interacting subsystems: epithelial, stromal, immune, and microbial elements that coevolve with their environment (<xref ref-type="bibr" rid="B4">4</xref>). Complexity theory, developed from systems physics, network theory, and ecology, privileges interactions over isolated entities, emergence over linear causality, and historicity over repetition (<xref ref-type="bibr" rid="B5">5</xref>). Applied to colorectal cancer, this framework positions the tumor as a dynamic ecosystem sustained by feedback loops, cooperation, and competition among its cellular and molecular components (<xref ref-type="bibr" rid="B6">6</xref>).</p>
</sec>
<sec id="s2">
<label>2</label>
<title>Methods</title>
<p>An integrative conceptual review was conducted to synthesize Hanahan&#x2019;s 2022 hallmarks framework with literature on complex systems theory, tumor ecology, and colorectal carcinogenesis. The approach was explicitly non-systematic but analytically structured.</p>
<p>Relevant sources were identified through purposive searches in PubMed and Google Scholar, complemented by backward and forward citation tracking from seminal papers in cancer systems biology, complexity science, and colorectal cancer. Priority was given to: (i) highly cited conceptual and theoretical articles on cancer as a complex adaptive system; (ii) reviews and perspectives on tumor ecosystems, multiscale modeling, and systems oncology; and (iii) key empirical and translational works in colorectal cancer that illustrate emergent, network-level behaviors rather than isolated molecular events.</p>
<p>For the conceptual mapping, each hallmark and enabling characteristic was analyzed using predefined questions (<xref ref-type="bibr" rid="B1">1</xref>): Which interactions (cell&#x2013;cell, cell&#x2013;microenvironment, cell&#x2013;microbiome) are necessary for this hallmark to manifest? (<xref ref-type="bibr" rid="B2">2</xref>) Which core properties of complex systems (nonlinearity, emergence, feedback, openness, interdependence, historical dependence) are required to sustain it? (<xref ref-type="bibr" rid="B3">3</xref>) How does the hallmark contribute to system-level adaptation or state transitions? Based on these criteria, hallmarks were iteratively assigned to one or more complexity properties, with emphasis on parsimony and internal coherence rather than exhaustive categorization. The objective was not to re-interpret primary molecular data but to construct a coherent systemic ontology of cancer grounded in established theoretical and experimental literature.</p>
</sec>
<sec id="s3" sec-type="results">
<label>3</label>
<title>Results</title>
<sec id="s3_1">
<label>3.1</label>
<title>The colorectal tumor as a complex adaptive system</title>
<p>Colorectal cancer represents a multilevel system composed of genetically unstable epithelial cells, stromal elements, immune infiltrates, vascular networks, and microbiota, all interacting within a dynamic intestinal environment (<xref ref-type="bibr" rid="B7">7</xref>). Global behavior emerges from local interactions and feedback mechanisms that cannot be predicted from any single component. The tumor behaves as a self-organizing structure, maintaining metastable states far from equilibrium through continuous energy and information exchange (<xref ref-type="bibr" rid="B8">8</xref>).</p>
</sec>
<sec id="s3_2">
<label>3.2</label>
<title>Mapping the hallmarks to complexity properties</title>
<p>Each hallmark of cancer reflects a manifestation of systemic dynamics rather than isolated molecular events. Sustained proliferative signaling arises from self-reinforcing feedback circuits, such as WNT&#x2013;MAPK&#x2013;EGFR cascades, which function as dynamic attractors in non-linear systems (<xref ref-type="bibr" rid="B9">9</xref>). Evading growth suppressors involves collective reorganization of tissue architecture, as loss of SMAD4 or APC disrupts epithelial containment and triggers adaptive pattern formation (<xref ref-type="bibr" rid="B10">10</xref>).</p>
<p>Resistance to cell death exemplifies system-level stabilization through positive feedback loops involving p53, NF-&#x3ba;B, BCL2, and HIF-1&#x3b1; (<xref ref-type="bibr" rid="B11">11</xref>). Replicative immortality reflects the open, dissipative nature of tumors that maintain energy fluxes to resist entropy (<xref ref-type="bibr" rid="B12">12</xref>). Induced angiogenesis operates as a recursive feedback process driven by HIF-1&#x3b1; and VEGF signaling under hypoxia (<xref ref-type="bibr" rid="B13">13</xref>).</p>
<p>Invasion and metastasis emerge as collective behaviors resulting from coordinated cell&#x2013;matrix&#x2013;immune interactions (<xref ref-type="bibr" rid="B14">14</xref>). Metabolic reprogramming underscores the system&#x2019;s openness, allowing adaptive exchanges of energy and metabolites with the host (<xref ref-type="bibr" rid="B15">15</xref>). Immune evasion, finally, represents a dynamic coevolutionary process between tumor and immune system (<xref ref-type="bibr" rid="B16">16</xref>).</p>
<p>The enabling characteristics, genomic instability and tumor-promoting inflammation, sustain adaptation by introducing variability and historical memory into the system (<xref ref-type="bibr" rid="B17">17</xref>). Together, these hallmarks define cancer not as a collection of traits but as an emergent organization shaped by nonlinearity and feedback.</p>
<p>The conceptual mapping between hallmarks and complexity-theory properties is summarized in <xref ref-type="table" rid="T1"><bold>Table&#xa0;1</bold></xref>. For each hallmark, the table indicates the dominant systemic properties involved (e.g., nonlinearity, emergence, feedback, openness, historical dependence) and provides a concise explanation of how these properties manifest in colorectal cancer as a complex adaptive system.</p>
<table-wrap id="T1" position="float">
<label>Table&#xa0;1</label>
<caption>
<p>Mapping of Hanahan&#x2019;s hallmarks of cancer (2022 update) onto core properties of complex adaptive systems in colorectal cancer.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="top" align="center">Hallmark/new dimension (Hanahan 2022)</th>
<th valign="top" align="center">Dominant complexity properties</th>
<th valign="top" align="center">Conceptual link in colorectal cancer as a complex adaptive system</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">Sustaining proliferative signaling</td>
<td valign="top" align="left">Nonlinearity; feedback; emergence</td>
<td valign="top" align="left">WNT&#x2013;MAPK&#x2013;EGFR self-reinforcing loops act as dynamic attractors where small perturbations generate disproportionate proliferative shifts.</td>
</tr>
<tr>
<td valign="top" align="left">Evading growth suppressors</td>
<td valign="top" align="left">Interdependence; emergence; historical dependence</td>
<td valign="top" align="left">APC/SMAD4 disruption alters epithelial architecture, producing emergent dysplastic patterns not explainable by single-gene effects.</td>
</tr>
<tr>
<td valign="top" align="left">Resisting cell death</td>
<td valign="top" align="left">Feedback; nonlinearity; historical dependence</td>
<td valign="top" align="left">Interacting p53&#x2013;NF-&#x3ba;B&#x2013;BCL2&#x2013;HIF-1&#x3b1; networks generate multistable survival regimes modulated by local stress conditions.</td>
</tr>
<tr>
<td valign="top" align="left">Enabling replicative immortality</td>
<td valign="top" align="left">Openness; dissipative structure; historical dependence</td>
<td valign="top" align="left">Telomere maintenance and sustained energy flux allow persistence far from equilibrium, embedding evolutionary memory.</td>
</tr>
<tr>
<td valign="top" align="left">Inducing angiogenesis</td>
<td valign="top" align="left">Feedback; openness; interdependence</td>
<td valign="top" align="left">Hypoxia-driven HIF-1&#x3b1;/VEGF signaling couples metabolic demand to vascular remodeling in co-evolving spatial niches.</td>
</tr>
<tr>
<td valign="top" align="left">Activating invasion and metastasis</td>
<td valign="top" align="left">Emergence; interdependence; nonlinearity</td>
<td valign="top" align="left">Collective migration and matrix remodeling arise from coordinated epithelial&#x2013;stromal&#x2013;immune interactions.</td>
</tr>
<tr>
<td valign="top" align="left">Deregulating cellular energetics</td>
<td valign="top" align="left">Openness; feedback; emergence</td>
<td valign="top" align="left">Warburg-like metabolic shifts reflect adaptive redistribution of energy across tumor&#x2013;stroma&#x2013;host interfaces.</td>
</tr>
<tr>
<td valign="top" align="left">Avoiding immune destruction</td>
<td valign="top" align="left">Coevolution; feedback; historical dependence</td>
<td valign="top" align="left">Iterative selection between tumor clones and immune infiltrates generates hot/altered/cold immune states.</td>
</tr>
<tr>
<td valign="top" align="left">Genome instability and mutation (enabling characteristic)</td>
<td valign="top" align="left">Historical dependence; variability generation</td>
<td valign="top" align="left">Ongoing instability expands the system&#x2019;s evolutionary state space, increasing adaptability under therapy.</td>
</tr>
<tr>
<td valign="top" align="left">Tumor-promoting inflammation (enabling characteristic)</td>
<td valign="top" align="left">Feedback; openness; emergence</td>
<td valign="top" align="left">Cytokine&#x2013;stromal&#x2013;epithelial loops reinforce pro-tumor attractor states and microenvironmental restructuring.</td>
</tr>
<tr>
<td valign="top" align="left">Phenotypic plasticity (new hallmark)</td>
<td valign="top" align="left">Nonlinearity; multistability; emergence</td>
<td valign="top" align="left">EMT&#x2013;MET transitions represent shifts between attractor states enabling rapid adaptation to selective pressures.</td>
</tr>
<tr>
<td valign="top" align="left">Non-mutational epigenetic reprogramming (new hallmark)</td>
<td valign="top" align="left">Historical dependence; network reconfiguration</td>
<td valign="top" align="left">Epigenetic remodeling alters regulatory topology, storing environmental information without changing DNA sequence.</td>
</tr>
<tr>
<td valign="top" align="left">Polymorphic microbiomes (new hallmark)</td>
<td valign="top" align="left">Openness; interdependence; feedback</td>
<td valign="top" align="left">Microbiome&#x2013;immune&#x2013;metabolic coupling reshapes the fitness landscape for tumor evolution.</td>
</tr>
<tr>
<td valign="top" align="left">Senescence and SASP (new hallmark)</td>
<td valign="top" align="left">Historical dependence; feedback; emergence</td>
<td valign="top" align="left">Senescent cells act as slow nodes releasing SASP mediators that restructure niches and modulate state transitions.</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="s3_3">
<label>3.3</label>
<title>New dimensions as expressions of complexity</title>
<p>The new dimensions proposed by Hanahan (<xref ref-type="bibr" rid="B3">3</xref>) deepen this systemic reading. Phenotypic plasticity corresponds to transitions between attractor states within the tumor&#x2019;s dynamic landscape (<xref ref-type="bibr" rid="B3">3</xref>). Non-mutational epigenetic reprogramming alters network topology without changing DNA sequence, conferring adaptability and memory (<xref ref-type="bibr" rid="B18">18</xref>). The microbiome acts as an open coupled environment influencing inflammation, immunity, and metabolism (<xref ref-type="bibr" rid="B18">18</xref>, <xref ref-type="bibr" rid="B19">19</xref>). Senescent cells function as &#x201c;slow nodes,&#x201d; releasing inflammatory mediators that reshape the microenvironment and modulate state transitions (<xref ref-type="bibr" rid="B20">20</xref>).</p>
</sec>
</sec>
<sec id="s4" sec-type="discussion">
<label>4</label>
<title>Discussion</title>
<p>Colorectal cancer, when seen through the lens of complexity, ceases to be a sum of mutations and becomes an adaptive network governed by universal principles: emergence, feedback, self-organization, and openness. This paradigm explains heterogeneity and therapeutic resistance not as failures of precision medicine but as inevitable consequences of living systems capable of adaptation. It encourages the integration of multiscale models, agent-based simulations, and network approaches that incorporate molecular, ecological, and temporal data.</p>
<p>Understanding CRC as a complex system reframes therapy as ecological modulation rather than eradication. Targeting intercellular communication, metabolic cooperation, and microenvironmental dependencies may prove more effective than inhibiting single pathways. This shift aligns oncology with systems biology and network science, unifying the molecular and ecological dimensions of cancer.</p>
<sec id="s4_1">
<label>4.1</label>
<title>Clinical translation</title>
<p>Understanding colorectal cancer as a complex adaptive system has important therapeutic implications. This framework shifts the focus from targeting isolated molecular pathways toward modulating system-level interactions that sustain tumor organization. From a therapeutic standpoint, complexity theory supports strategies that disrupt key ecological relationships&#x2014;such as metabolic cooperation, stromal&#x2013;epithelial feedback, and immune&#x2013;tumor coevolution&#x2014;rather than exclusively inhibiting single driver alterations. It also encourages adaptive and evolution-informed treatment designs, in which therapy is guided by anticipated state transitions, resistance trajectories, and the stabilization of less aggressive attractor states. Furthermore, integrating microbiome composition, immune contexture and spatial tissue organization into clinical decision-making may enable more robust stratification than purely genomic profiling. Finally, acknowledging the nonlinear and emergent nature of tumor behavior underscores the value of multiscale, longitudinal data and computational modeling as complementary tools for predicting responses and tailoring interventions. Taken together, this conceptual framework offers a path toward more resilient, ecologically informed therapeutic strategies in colorectal cancer.</p>
</sec>
</sec>
<sec id="s5" sec-type="conclusions">
<label>5</label>
<title>Conclusions</title>
<p>This systems-oriented interpretation of colorectal cancer is consistent with advances in network biology, multiscale modeling, and ecological approaches to cancer, which conceptualize tumors as dynamic, interacting networks rather than linear molecular cascades (<xref ref-type="bibr" rid="B21">21</xref>&#x2013;<xref ref-type="bibr" rid="B25">25</xref>). Recent work in cancer systems medicine and patient-specific mechanistic modeling further supports the integration of computational, ecological, and evolutionary frameworks to capture tumor behavior across scales (<xref ref-type="bibr" rid="B26">26</xref>&#x2013;<xref ref-type="bibr" rid="B30">30</xref>).</p>
<p>Colorectal cancer should be conceived as a complex adaptive system where hallmarks emerge from collective organization rather than from discrete molecular events. The new dimensions proposed by Hanahan do not merely expand the list of hallmarks; they redefine cancer as an ecological, evolutionary, and self-organizing process. Embracing complexity offers not only a deeper theoretical understanding but also a pathway toward predictive and integrative oncology.</p>
</sec>
</body>
<back>
<sec id="s6" sec-type="data-availability">
<title>Data availability statement</title>
<p>The original contributions presented in the study are included in the article/supplementary material. Further inquiries can be directed to the corresponding author.</p></sec>
<sec id="s7" sec-type="author-contributions">
<title>Author contributions</title>
<p>LB: Validation, Conceptualization, Methodology, Supervision, Data curation, Investigation, Funding acquisition, Writing &#x2013; original draft, Project administration, Writing &#x2013; review &amp; editing, Formal Analysis, Resources, Software, Visualization.</p></sec>
<sec id="s9" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The authors declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec>
<sec id="s10" sec-type="ai-statement">
<title>Generative AI statement</title>
<p>The author(s) declared that generative AI was used in the creation of this manuscript. Generative AI was used solely for language editing and minor stylistic refinement. The author takes full responsibility for the content and interpretation of the manuscript.</p>
<p>Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.</p></sec>
<sec id="s11" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p></sec>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Fearon</surname> <given-names>ER</given-names></name>
<name><surname>Vogelstein</surname> <given-names>B</given-names></name>
</person-group>. 
<article-title>A genetic model for colorectal tumorigenesis</article-title>. <source>Cell</source>. (<year>1990</year>) <volume>61</volume>:<page-range>759&#x2013;67</page-range>., PMID: <pub-id pub-id-type="pmid">2188735</pub-id>
</mixed-citation>
</ref>
<ref id="B2">
<label>2</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Greaves</surname> <given-names>M</given-names></name>
<name><surname>Maley</surname> <given-names>CC</given-names></name>
</person-group>. 
<article-title>Clonal evolution in cancer</article-title>. <source>Nature</source>. (<year>2012</year>) <volume>481</volume>:<page-range>306&#x2013;13</page-range>.
</mixed-citation>
</ref>
<ref id="B3">
<label>3</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Hanahan</surname> <given-names>D</given-names></name>
</person-group>. 
<article-title>Hallmarks of cancer: new dimensions</article-title>. <source>Cancer Discov</source>. (<year>2022</year>) <volume>12</volume>:<fpage>31</fpage>&#x2013;<lpage>46</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1158/2159-8290.CD-21-1059</pub-id>, PMID: <pub-id pub-id-type="pmid">35022204</pub-id>
</mixed-citation>
</ref>
<ref id="B4">
<label>4</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Quail</surname> <given-names>DF</given-names></name>
<name><surname>Joyce</surname> <given-names>JA</given-names></name>
</person-group>. 
<article-title>Microenvironmental regulation of tumor progression and metastasis</article-title>. <source>Nat Med</source>. (<year>2013</year>) <volume>19</volume>:<page-range>1423&#x2013;37</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nm.3394</pub-id>, PMID: <pub-id pub-id-type="pmid">24202395</pub-id>
</mixed-citation>
</ref>
<ref id="B5">
<label>5</label>
<mixed-citation publication-type="book">
<person-group person-group-type="author">
<name><surname>Bar-Yam</surname> <given-names>Y</given-names></name>
</person-group>. <source>Dynamics of complex systems</source>. <publisher-loc>Reading</publisher-loc>: 
<publisher-name>Addison-Wesley</publisher-name> (<year>1997</year>).
</mixed-citation>
</ref>
<ref id="B6">
<label>6</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Merlo</surname> <given-names>LMF</given-names></name>
<name><surname>Pepper</surname> <given-names>JW</given-names></name>
<name><surname>Reid</surname> <given-names>BJ</given-names></name>
<name><surname>Maley</surname> <given-names>CC</given-names></name>
</person-group>. 
<article-title>Cancer as an evolutionary and ecological process</article-title>. <source>Nat Rev Cancer</source>. (<year>2006</year>) <volume>6</volume>:<page-range>924&#x2013;35</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nrc2013</pub-id>, PMID: <pub-id pub-id-type="pmid">17109012</pub-id>
</mixed-citation>
</ref>
<ref id="B7">
<label>7</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Baghban</surname> <given-names>R</given-names></name>
<name><surname>Roshangar</surname> <given-names>L</given-names></name>
<name><surname>Jahanban-Esfahlan</surname> <given-names>R</given-names></name>
<name><surname>Seidi</surname> <given-names>K</given-names></name>
<name><surname>Ebrahimi-Kalan</surname> <given-names>A</given-names></name>
<name><surname>Jaymand</surname> <given-names>M</given-names></name>
<etal/>
</person-group>. 
<article-title>Tumor microenvironment complexity and therapeutic implications at a glance</article-title>. <source>Cell Commun Signal</source>. (<year>2020</year>) <volume>18</volume>:<fpage>59</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s12964-020-0530-4</pub-id>, PMID: <pub-id pub-id-type="pmid">32264958</pub-id>
</mixed-citation>
</ref>
<ref id="B8">
<label>8</label>
<mixed-citation publication-type="book">
<person-group person-group-type="author">
<name><surname>Prigogine</surname> <given-names>I</given-names></name>
<name><surname>Stengers</surname> <given-names>I</given-names></name>
</person-group>. <source>The new alliance: metamorphosis of science</source>. <publisher-loc>Madrid</publisher-loc>: 
<publisher-name>Alianza Editorial</publisher-name> (<year>1983</year>).
</mixed-citation>
</ref>
<ref id="B9">
<label>9</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Segditsas</surname> <given-names>S</given-names></name>
<name><surname>Tomlinson</surname> <given-names>I</given-names></name>
</person-group>. 
<article-title>Colorectal cancer and genetic alterations in the Wnt pathway</article-title>. <source>Oncogene</source>. (<year>2006</year>) <volume>25</volume>:<page-range>7531&#x2013;7</page-range>., PMID: <pub-id pub-id-type="pmid">17143297</pub-id>
</mixed-citation>
</ref>
<ref id="B10">
<label>10</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Becht</surname> <given-names>E</given-names></name>
<name><surname>de Reyni&#xe8;s</surname> <given-names>A</given-names></name>
<name><surname>Giraldo</surname> <given-names>NA</given-names></name>
<name><surname>Pilati</surname> <given-names>C</given-names></name>
<name><surname>Buttard</surname> <given-names>B</given-names></name>
<name><surname>Lacroix</surname> <given-names>L</given-names></name>
<etal/>
</person-group>. 
<article-title>Immune and stromal classification of colorectal cancer and its clinical relevance</article-title>. <source>Clin Cancer Res</source>. (<year>2016</year>) <volume>22</volume>:<page-range>4057&#x2013;66</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1158/1078-0432.CCR-15-2879</pub-id>, PMID: <pub-id pub-id-type="pmid">26994146</pub-id>
</mixed-citation>
</ref>
<ref id="B11">
<label>11</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Vousden</surname> <given-names>KH</given-names></name>
<name><surname>Lane</surname> <given-names>DP</given-names></name>
</person-group>. 
<article-title>p53 in health and disease</article-title>. <source>Nat Rev Mol Cell Biol</source>. (<year>2007</year>) <volume>8</volume>:<page-range>275&#x2013;83</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nrm2147</pub-id>, PMID: <pub-id pub-id-type="pmid">17380161</pub-id>
</mixed-citation>
</ref>
<ref id="B12">
<label>12</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Carmeliet</surname> <given-names>P</given-names></name>
<name><surname>Jain</surname> <given-names>RK</given-names></name>
</person-group>. 
<article-title>Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases</article-title>. <source>Nat Rev Drug Discov</source>. (<year>2011</year>) <volume>10</volume>:<page-range>417&#x2013;27</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nrd3455</pub-id>, PMID: <pub-id pub-id-type="pmid">21629292</pub-id>
</mixed-citation>
</ref>
<ref id="B13">
<label>13</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Lambert</surname> <given-names>AW</given-names></name>
<name><surname>Pattabiraman</surname> <given-names>DR</given-names></name>
<name><surname>Weinberg</surname> <given-names>RA</given-names></name>
</person-group>. 
<article-title>Emerging biological principles of metastasis</article-title>. <source>Cell</source>. (<year>2017</year>) <volume>168</volume>:<page-range>670&#x2013;91</page-range>.
</mixed-citation>
</ref>
<ref id="B14">
<label>14</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Vander Heiden</surname> <given-names>MG</given-names></name>
<name><surname>Cantley</surname> <given-names>LC</given-names></name>
<name><surname>Thompson</surname> <given-names>CB</given-names></name>
</person-group>. 
<article-title>Understanding the Warburg effect: the metabolic requirements of cell proliferation</article-title>. <source>Science</source>. (<year>2009</year>) <volume>324</volume>:<page-range>1029&#x2013;33</page-range>., PMID: <pub-id pub-id-type="pmid">19460998</pub-id>
</mixed-citation>
</ref>
<ref id="B15">
<label>15</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Galon</surname> <given-names>J</given-names></name>
<name><surname>Bruni</surname> <given-names>D</given-names></name>
</person-group>. 
<article-title>Approaches to treat immune hot, altered and cold tumours with combination immunotherapies</article-title>. <source>Nat Rev Drug Discov</source>. (<year>2019</year>) <volume>18</volume>:<fpage>197</fpage>&#x2013;<lpage>218</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41573-018-0007-y</pub-id>, PMID: <pub-id pub-id-type="pmid">30610226</pub-id>
</mixed-citation>
</ref>
<ref id="B16">
<label>16</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Burrell</surname> <given-names>RA</given-names></name>
<name><surname>McGranahan</surname> <given-names>N</given-names></name>
<name><surname>Bartek</surname> <given-names>J</given-names></name>
<name><surname>Swanton</surname> <given-names>C</given-names></name>
</person-group>. 
<article-title>The causes and consequences of genetic heterogeneity in cancer evolution</article-title>. <source>Nature</source>. (<year>2013</year>) <volume>501</volume>:<page-range>338&#x2013;45</page-range>.
</mixed-citation>
</ref>
<ref id="B17">
<label>17</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Baylin</surname> <given-names>SB</given-names></name>
<name><surname>Jones</surname> <given-names>PA</given-names></name>
</person-group>. 
<article-title>Epigenetic determinants of cancer</article-title>. <source>Cold Spring Harb Perspect Biol</source>. (<year>2016</year>) <volume>8</volume>:<elocation-id>a019505</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1101/cshperspect.a019505</pub-id>, PMID: <pub-id pub-id-type="pmid">27194046</pub-id>
</mixed-citation>
</ref>
<ref id="B18">
<label>18</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Garrett</surname> <given-names>WS</given-names></name>
</person-group>. 
<article-title>Cancer and the microbiota</article-title>. <source>Science</source>. (<year>2015</year>) <volume>348</volume>:<page-range>80&#x2013;6</page-range>.
</mixed-citation>
</ref>
<ref id="B19">
<label>19</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Schwabe</surname> <given-names>RF</given-names></name>
<name><surname>Jobin</surname> <given-names>C</given-names></name>
</person-group>. 
<article-title>The microbiome and cancer</article-title>. <source>Nat Rev Cancer</source>. (<year>2013</year>) <volume>13</volume>:<page-range>800&#x2013;12</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nrc3610</pub-id>, PMID: <pub-id pub-id-type="pmid">24132111</pub-id>
</mixed-citation>
</ref>
<ref id="B20">
<label>20</label>
<mixed-citation publication-type="book">
<person-group person-group-type="author">
<name><surname>Newman</surname> <given-names>MEJ</given-names></name>
</person-group>. <source>Networks: an introduction</source>. <publisher-loc>Oxford</publisher-loc>: 
<publisher-name>Oxford University Press</publisher-name> (<year>2010</year>).
</mixed-citation>
</ref>
<ref id="B21">
<label>21</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Barab&#xe1;si</surname> <given-names>AL</given-names></name>
<name><surname>Oltvai</surname> <given-names>ZN</given-names></name>
</person-group>. 
<article-title>Network biology: understanding the cell&#x2019;s functional organization</article-title>. <source>Nat Rev Genet</source>. (<year>2004</year>) <volume>5</volume>:<page-range>101&#x2013;13</page-range>.
</mixed-citation>
</ref>
<ref id="B22">
<label>22</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Vogelstein</surname> <given-names>B</given-names></name>
<name><surname>Papadopoulos</surname> <given-names>N</given-names></name>
<name><surname>Velculescu</surname> <given-names>VE</given-names></name>
<name><surname>Zhou</surname> <given-names>S</given-names></name>
<name><surname>Diaz</surname> <given-names>LA</given-names></name>
<name><surname>Kinzler</surname> <given-names>KW</given-names></name>
</person-group>. 
<article-title>Cancer genome landscapes</article-title>. <source>Science</source>. (<year>2013</year>) <volume>339</volume>:<page-range>1546&#x2013;58</page-range>.
</mixed-citation>
</ref>
<ref id="B23">
<label>23</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Campisi</surname> <given-names>J</given-names></name>
</person-group>. 
<article-title>Aging, cellular senescence, and cancer</article-title>. <source>Annu Rev Physiol</source>. (<year>2013</year>) <volume>75</volume>:<fpage>685</fpage>&#x2013;<lpage>705</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1146/annurev-physiol-030212-183653</pub-id>, PMID: <pub-id pub-id-type="pmid">23140366</pub-id>
</mixed-citation>
</ref>
<ref id="B24">
<label>24</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Copp&#xe9;</surname> <given-names>JP</given-names></name>
<name><surname>Desprez</surname> <given-names>PY</given-names></name>
<name><surname>Krtolica</surname> <given-names>A</given-names></name>
<name><surname>Campisi</surname> <given-names>J</given-names></name>
</person-group>. 
<article-title>The senescence-associated secretory phenotype: the dark side of tumor suppression</article-title>. <source>Annu Rev Pathol</source>. (<year>2010</year>) <volume>5</volume>:<fpage>99</fpage>&#x2013;<lpage>118</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1146/annurev-pathol-121808-102144</pub-id>, PMID: <pub-id pub-id-type="pmid">20078217</pub-id>
</mixed-citation>
</ref>
<ref id="B25">
<label>25</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Swanton</surname> <given-names>C</given-names></name>
</person-group>. 
<article-title>Embracing cancer complexity: hallmarks of systemic disease</article-title>. <source>Cell</source>. (<year>2024</year>) <volume>187</volume>:<fpage>479</fpage>&#x2013;<lpage>502</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.cell.2024.01.003</pub-id>, PMID: <pub-id pub-id-type="pmid">38552609</pub-id>
</mixed-citation>
</ref>
<ref id="B26">
<label>26</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Karimi</surname> <given-names>MR</given-names></name>
<name><surname>Hosseini</surname> <given-names>M</given-names></name>
<name><surname>Biglar</surname> <given-names>M</given-names></name>
<name><surname>Ramezani</surname> <given-names>M</given-names></name>
<name><surname>Zali</surname> <given-names>A</given-names></name>
<name><surname>Rezaei</surname> <given-names>N</given-names></name>
<etal/>
</person-group>. 
<article-title>Prospects and challenges of cancer systems medicine</article-title>. <source>Brief Bioinform</source>. (<year>2022</year>) <volume>23</volume>:<elocation-id>bbab343</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/bib/bbab343</pub-id>, PMID: <pub-id pub-id-type="pmid">34471925</pub-id>
</mixed-citation>
</ref>
<ref id="B27">
<label>27</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Lorenzo</surname> <given-names>G</given-names></name>
<name><surname>Ayensa-Jim&#xe9;nez</surname> <given-names>J</given-names></name>
<name><surname>G&#xf3;mez</surname> <given-names>H</given-names></name>
<name><surname>Doblare</surname> <given-names>M</given-names></name>
<name><surname>Cegonino</surname> <given-names>J</given-names></name>
<name><surname>Mart&#xed;nez</surname> <given-names>MA</given-names></name>
<etal/>
</person-group>. 
<article-title>Patient-specific mechanistic models of tumor growth and treatment</article-title>. <source>Annu Rev BioMed Eng</source>. (<year>2024</year>) <volume>26</volume>:<fpage>1</fpage>&#x2013;<lpage>27</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1146/annurev-bioeng-082420-124839</pub-id>
</mixed-citation>
</ref>
<ref id="B28">
<label>28</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Aguad&#xe9;-Gorgori&#xf3;</surname> <given-names>G</given-names></name>
<name><surname>Yan</surname> <given-names>J</given-names></name>
<name><surname>Gore</surname> <given-names>J</given-names></name>
</person-group>. 
<article-title>Modeling tumors as complex ecological systems</article-title>. <source>iScience</source>. (<year>2024</year>) <volume>27</volume>:<elocation-id>108123</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.isci.2024.108123</pub-id>
</mixed-citation>
</ref>
<ref id="B29">
<label>29</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Wang</surname> <given-names>J</given-names></name>
<name><surname>Wang</surname> <given-names>E</given-names></name>
<name><surname>Chen</surname> <given-names>L</given-names></name>
</person-group>. 
<article-title>Data-driven universal insights into tumorigenesis through hallmark-based gene regulatory networks</article-title>. <source>NPJ Syst Biol Appl</source>. (<year>2025</year>) <volume>11</volume>:<fpage>12</fpage>&#x2013;<lpage>25</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41540-025-00463-1</pub-id>
</mixed-citation>
</ref>
<ref id="B30">
<label>30</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Pavlova</surname> <given-names>NN</given-names></name>
<name><surname>Thompson</surname> <given-names>CB</given-names></name>
</person-group>. 
<article-title>The emerging hallmarks of cancer metabolism</article-title>. <source>Cell Metab</source>. (<year>2016</year>) <volume>23</volume>:<fpage>27</fpage>&#x2013;<lpage>47</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.cmet.2015.12.006</pub-id>, PMID: <pub-id pub-id-type="pmid">26771115</pub-id>
</mixed-citation>
</ref>
</ref-list>
<fn-group>
<fn id="n1" fn-type="custom" custom-type="edited-by">
<p>Edited by: <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1500453">Antonio Mario Scanu</ext-link>, University of Sassari, Italy</p></fn>
<fn id="n2" fn-type="custom" custom-type="reviewed-by">
<p>Reviewed by: <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1251218">Luca Ermini</ext-link>, University of Camerino, Italy</p></fn>
</fn-group>
</back>
</article>